Absci Corporation (ABSI) is a biotechnology company focused on AI-driven drug discovery. Here's a detailed analysis to help you evaluate whether it's a good stock to buy and hold: (as of 17 October 2025) • Stock Price: $4.575 (USD), down 6.06% from the previous close. • Market Cap: $684.07 million (USD). • 52-Week Range : $2.01 to $6.33 (USD). • P/E Ratio (TTM) : Negative (-4.85), indicating the company is not profitable. • Price-to-Sales Ratio (TTM) : 165.31, suggesting high valuation relative to revenue. • Earnings per Share (TTM) : -$0.94. • Analyst Target Price: Mean estimate of $7.815 (range: $5.89 to $9.00), implying potential upside. Financial Health: • Return on Assets (ROA) : -31.26%, indicating inefficiency in generating profits from assets. • Return on E
$Palantir Technologies Inc.(PLTR)$ we are Champions and you raise me up to happiness [Cool] @MillionaireTiger @TigerBrokers @Zarkness @koolgal @HelenJanet @vodkalime @ahyi @GoodLife99 @Fenger1188